Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures
Milestone Scientific highlighted growing clinical adoption of its CompuFlo Epidural System following a new peer-reviewed study from the University of Texas Medical Branch. The study, published in Operative Neurosurgery, found that CompuFlo-guided epidural access during spinal cord stimulator implantation was associated with a 91% reduction in the odds of composite complications compared to conventional techniques.
Key figures
- Complication reduction odds
- 91%
- Academic institutions evaluating
- 40+
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.